# COVID-SErology in Rheumatoid Arthritis (COVID-19)

> **NCT04407559** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 216 (actual)

## Conditions studied

- COVID-19
- Rheumatoid Arthritis

## Interventions

- **OTHER:** Serological analyses to be lead on a pre-existing biobank

## Key facts

- **NCT ID:** NCT04407559
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-30
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2020-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04407559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04407559, "COVID-SErology in Rheumatoid Arthritis (COVID-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04407559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*